These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


534 related items for PubMed ID: 23764864

  • 1. Predictors of exercise-induced oxygen desaturation in systemic sclerosis patients with interstitial lung disease.
    Someya F, Mugii N, Hasegawa M, Yahata T, Nakagawa T.
    Respir Care; 2014 Jan; 59(1):75-80. PubMed ID: 23764864
    [Abstract] [Full Text] [Related]

  • 2. DLCO versus DLCO/VA as predictors of pulmonary gas exchange.
    Kaminsky DA, Whitman T, Callas PW.
    Respir Med; 2007 May; 101(5):989-94. PubMed ID: 17055236
    [Abstract] [Full Text] [Related]

  • 3. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
    Rizzi M, Sarzi-Puttini P, Airoldi A, Antivalle M, Battellino M, Atzeni F.
    Clin Exp Rheumatol; 2015 May; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
    [Abstract] [Full Text] [Related]

  • 4. Exercise-induced oxygen desaturation in COPD patients without resting hypoxemia.
    Andrianopoulos V, Franssen FM, Peeters JP, Ubachs TJ, Bukari H, Groenen M, Burtin C, Vogiatzis I, Wouters EF, Spruit MA.
    Respir Physiol Neurobiol; 2014 Jan 01; 190():40-6. PubMed ID: 24121092
    [Abstract] [Full Text] [Related]

  • 5. Predictors of oxygen desaturation during submaximal exercise in 8,000 patients.
    Hadeli KO, Siegel EM, Sherrill DL, Beck KC, Enright PL.
    Chest; 2001 Jul 01; 120(1):88-92. PubMed ID: 11451821
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.
    Fujimoto Y, Oki Y, Kaneko M, Sakai H, Misu S, Yamaguchi T, Mitani Y, Yasuda H, Ishikawa A.
    Int J Chron Obstruct Pulmon Dis; 2017 Jul 01; 12():2669-2675. PubMed ID: 28919734
    [Abstract] [Full Text] [Related]

  • 7. Quantitative 15 steps exercise oximetry as a marker of disease severity in patients with chronic obstructive pulmonary disease.
    Kramer MR, Krivoruk V, Lebzelter J, Liani M, Fink G.
    Isr Med Assoc J; 1999 Nov 01; 1(3):165-8. PubMed ID: 10731326
    [Abstract] [Full Text] [Related]

  • 8. Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease.
    Moore OA, Proudman SM, Goh N, Corte TJ, Rouse H, Hennessy O, Morrisroe K, Thakkar V, Sahhar J, Roddy J, Youssef P, Gabbay E, Nash P, Zochling J, Stevens W, Nikpour M.
    Clin Exp Rheumatol; 2015 Nov 01; 33(4 Suppl 91):S111-6. PubMed ID: 26243401
    [Abstract] [Full Text] [Related]

  • 9. Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease.
    Le Gouellec N, Duhamel A, Perez T, Hachulla AL, Sobanski V, Faivre JB, Morell-Dubois S, Lambert M, Hatron PY, Hachulla E, Béhal H, Matran R, Launay D, Remy-Jardin M.
    PLoS One; 2017 Nov 01; 12(8):e0181692. PubMed ID: 28763468
    [Abstract] [Full Text] [Related]

  • 10. [Single-breath and rebreathing methods for measurement of pulmonary diffusing function: a comparative study].
    Liu QX, Zheng JP, Xie YQ, Guan WJ, Jiang CY, An JY, Yu XX, Liu WT, Gao Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul 01; 36(7):510-5. PubMed ID: 24262087
    [Abstract] [Full Text] [Related]

  • 11. High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.
    Wanchu A, Suryanaryana BS, Sharma S, Sharma A, Bambery P.
    Int J Rheum Dis; 2009 Sep 01; 12(3):239-42. PubMed ID: 20374353
    [Abstract] [Full Text] [Related]

  • 12. [Lung involvement in systemic sclerosis].
    Quadrelli S, Ciallella L, Catalán Pellet AC, Molinari L, Salvado A, Auad C, Spina JC.
    Medicina (B Aires); 2007 Sep 01; 67(5):429-35. PubMed ID: 18051224
    [Abstract] [Full Text] [Related]

  • 13. Factors relating to impaired stroke volume during the 6-minute walk test in patients with systemic sclerosis.
    Someya F, Mugii N, Oohata S.
    Clin Exp Rheumatol; 2016 Sep 01; 34 Suppl 100(5):152-156. PubMed ID: 27463117
    [Abstract] [Full Text] [Related]

  • 14. Impaired carbon monoxide diffusing capacity as a marker of limited systemic sclerosis.
    Trad S, Huong du LT, Frances C, Wechsler B, Cacoub P, Costedoat N, Haroche J, Piette JC, Hanslik T, Amoura Z.
    Eur J Intern Med; 2011 Dec 01; 22(6):e80-6. PubMed ID: 22075318
    [Abstract] [Full Text] [Related]

  • 15. Diffusing Pulmonary Capacity Measured During Effort: A Possible Early Marker of Pulmonary Involvement In Systemic Sclerosis.
    Legnani D, Rizzi M, Sarzi-Puttini P, Cristiano A, La Spina T, Frassanito F, Airoldi A, Atzeni F.
    Isr Med Assoc J; 2015 Dec 01; 17(12):739-43. PubMed ID: 26897974
    [Abstract] [Full Text] [Related]

  • 16. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC, Highland KB, Silver RM, Strange C.
    J Rheumatol; 2009 Feb 01; 36(2):330-6. PubMed ID: 19208563
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, Sterz MG, Chung J, FitzGerald JD, Seibold JR, Varga J, Theodore A, Wigley FM, Silver RM, Steen VD, Mayes MD, Connolly MK, Fessler BJ, Rothfield NF, Mubarak K, Molitor J, Tashkin DP, Scleroderma Lung Study Group.
    Arthritis Rheum; 2005 Feb 01; 52(2):592-600. PubMed ID: 15692967
    [Abstract] [Full Text] [Related]

  • 19. Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide.
    Rose L, Prins KW, Archer SL, Pritzker M, Weir EK, Misialek JR, Thenappan T.
    J Heart Lung Transplant; 2019 Feb 01; 38(2):145-155. PubMed ID: 30391191
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.